Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-08-20Clinical Trial Update: Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial update comparing two short-term therapies for type 2 diabetes to assess glycemic fluctuation and oxidative stress; …
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease [Phase 4]
A Phase 4 trial update reports that pioglitazone reduced left ventricular mass in patients with type 2 diabetes mellitus and ischemic heart …
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Study of MK-0893 on Glucagon-Induced Glycemic Excursion in Healthy Male Participants Following Intravenous Administration of Glucagon, Sandostatine® and Insulin (MK-0893-002) [Phase 1]
Phase 1 study evaluating MK-0893's effect on glucagon-induced glycemic excursions in healthy male participants following intravenous adminis…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED) [Phase 1]
A completed Phase 1 study evaluated the effects of sitagliptin (MK0431) in combination with metformin on incretin hormone concentrations. Th…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 Diabetes [Phase 3]
Phase 3 study evaluating daily oral TAK-875 (fasiglifam) 25 and 50 mg in Asia Pacific adults with Type 2 diabetes mellitus was terminated; r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors [Phase 4]
Clinical trial update evaluating the metabolic and cardiovascular effects of DPP-4 inhibitors and SGLT2 inhibitors in individuals with diabe…
-
FDA approval · 2015-08-18FDA Approved: NATEGLINIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for Dr. Reddy's Laboratories Limited for nateglinide (generic) under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: The Alberta Diet: Effectiveness Study [Phase 2]
Phase 2 results from the Alberta Diet effectiveness study in Type 2 diabetes have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes [Phase 3]
Phase 3 clinical trial evaluating ITCA-650 for type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease [Phase 4]
A Phase 4 trial reports that sitagliptin reduces left ventricular mass in normotensive patients with type 2 diabetes and coronary artery dis…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial update reports completion of a study evaluating the effects of rosiglitazone and metformin on metabolism in individ…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 open-label trial comparing Insulin VIAject with regular human insulin in type 2 diabetes; study completed.
-
FDA approval · 2015-08-17FDA Approved: GLIPIZIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for GLIPIZIDE AND METFORMIN HYDROCHLORIDE (Teva), a fixed-dose combination product. The action perta…
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin [Phase 2]
This Phase 2 study evaluated the safety, tolerability, efficacy, and pharmacokinetics/pharmacodynamics of three doses of BI 187004 over 28 d…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: A Study of the Efficacy and Safety of 4 Doses of Imeglimin After 24 Weeks of Treatment in Subjects With Type 2 Diabetes [Phase 2]
A Phase 2 study evaluated four doses of imeglimin over 24 weeks in adults with Type 2 Diabetes Mellitus. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin
A completed study investigating biomarkers for detecting vitamin B12 deficiency in people with type 2 diabetes who are treated with metformi…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Cold Stress Stimulate the Browing of Subcutaneous White Adipose in Healthy Adults [NA]
This clinical trial update reports a completed study examining whether cold stress stimulates browning of subcutaneous white adipose tissue …
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: 3-Month Trial Observation of A1c Change [NA]
The trial evaluating a 3-month observation of A1c change in Type 2 Diabetes was terminated.
-
FDA approval · 2015-08-07FDA Approved: SYMLINPEN — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for SYMLINPEN (pramlintide acetate) from AstraZeneca.
-
CLINICAL_TRIALS research · 2015-08-07Clinical Trial Update: Validation of a Patient Decision Aid for Type 2 Diabetes [NA]
Completed status update on a clinical trial validating a patient decision aid for Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-08-06Clinical Trial Update: Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population [Phase 4]
Phase 4 study evaluating the efficacy of Sitagliptin in a subgroup of young, non-obese Asian Indian adults with Type 2 diabetes, as part of …
-
CLINICAL_TRIALS research · 2015-08-06Clinical Trial Update: Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control [Phase 4]
This Phase 4 clinical trial update examines replacing syringes for insulin administration in elderly patients using insulin pens as part of …
-
CLINICAL_TRIALS research · 2015-08-06Clinical Trial Update: Empowerment and Support for the Diabetic Patient [NA]
A clinical trial update from Clalit Health Services related to a Type 2 diabetes study focusing on empowerment and support for patients; the…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial updates on the safety and tolerability of lixisenatide added to oral antidiabetic therapy in adults with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Effect of Treatment With Insulin VIAjectTM Compared to Regular Human Insulin and Insulin Lispro on Mealtime Blood Vessel Stress in Patients With Type 2 Diabetes Mellitus. [Phase 3]
Phase 3 trial comparing VIAject insulin with regular human insulin and insulin lispro in patients with Type 2 diabetes mellitus completed, a…